Literature DB >> 11264192

Thromboprophylaxis after replacement arthroplasty.

D P Thomas.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11264192      PMCID： PMC1119889          DOI： 10.1136/bmj.322.7288.686

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  11 in total

Review 1.  Recent advances in venous thromboembolic prophylaxis during and after total hip replacement.

Authors:  E A Salvati; V D Pellegrini; N E Sharrock; P A Lotke; D W Murray; H Potter; G H Westrich
Journal:  J Bone Joint Surg Am       Date:  2000-02       Impact factor: 5.284

Review 2.  Hemorrhagic complications of anticoagulant treatment.

Authors:  M N Levine; G Raskob; S Landefeld; C Kearon
Journal:  Chest       Date:  1998-11       Impact factor: 9.410

3.  Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial.

Authors: 
Journal:  Lancet       Date:  2000-04-15       Impact factor: 79.321

4.  Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients: a double-blind, randomized comparison. North American Fragmin Trial Investigators.

Authors:  R D Hull; G F Pineo; C Francis; D Bergqvist; C Fellenius; K Soderberg; A Holmqvist; M Mant; R Dear; B Baylis; A Mah; R Brant
Journal:  Arch Intern Med       Date:  2000-07-24

5.  Efficacy of prophylaxis against thromboembolism with intermittent pneumatic compression after primary and revision total hip arthroplasty.

Authors:  J A Hooker; P F Lachiewicz; S S Kelley
Journal:  J Bone Joint Surg Am       Date:  1999-05       Impact factor: 5.284

6.  Comparison of the use of a foot pump with the use of low-molecular-weight heparin for the prevention of deep-vein thrombosis after total hip replacement. A prospective, randomized trial.

Authors:  D Warwick; J Harrison; D Glew; A Mitchelmore; T J Peters; J Donovan
Journal:  J Bone Joint Surg Am       Date:  1998-08       Impact factor: 5.284

7.  Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement.

Authors:  D Bergqvist; G Benoni; O Björgell; H Fredin; U Hedlundh; S Nicolas; P Nilsson; G Nylander
Journal:  N Engl J Med       Date:  1996-09-05       Impact factor: 91.245

8.  Measurement of thrombin generation in whole blood--the effect of heparin and aspirin.

Authors:  H Kessels; S Béguin; H Andree; H C Hemker
Journal:  Thromb Haemost       Date:  1994-07       Impact factor: 5.249

9.  Collaborative overview of randomised trials of antiplatelet therapy--III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-22

10.  Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo.

Authors:  A Planes; N Vochelle; J Y Darmon; M Fagola; M Bellaud; Y Huet
Journal:  Lancet       Date:  1996-07-27       Impact factor: 79.321
View more
  1 in total

1.  Thromboprophylaxis after replacement arthroplasty. Many surgeons prefer not to prescribe chemoprophylaxis after arthroplasty.

Authors:  D A Macdonald
Journal:  BMJ       Date:  2001-06-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.